Expertise in
7
conditions

Antonello Pani

Cagliari, IT 
Expertise in
7
conditions
Cagliari, IT 

Overview

Antonello Pani practices practicing medicine in Cagliari, Italy.

Mr. Pani is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Glomerulonephritis, IgA Nephropathy, Membranous Nephropathy, Nephrectomy, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Cagliari, Italy
Other Locations
Monserrato, 09042, Italy
Milan, Italy
Sassari, Italy
Lecco, Italy
Ancona, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

95 Total Publications

A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy.
A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy.
Journal: Kidney international
Published: February 18, 2026

Frequently Asked Questions about Antonello Pani

Is Antonello Pani a top-rated expert for Glomerulonephritis?

MediFind is an objective health platform that identifies experts based on real-world data. Antonello Pani is classified as an Distinguished expert for Glomerulonephritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Antonello Pani participate in research or clinical trials?

Yes. Antonello Pani has published 95 articles and abstracts on conditions like Glomerulonephritis. You can view a list of Antonello Pani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pani's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile